Revlimid (lenalidomide) Disease area(s): Oncology/hematology Manufacturer(s): Bristol Myers Squibb 2024 Sales (USD): $5.77 billion Why it sold so well: In 2024, BMS Revlimid generated $5.77 billion in global revenue, maintaining its position as one of the companys top-selling products despite facing generic competition
Compounding pharmacies are experts at stepping in when drug shortages occur
Research in people with diabetes has found that those treated with GLP-1 receptor agonists were almost twice as likely to test positive for SIBO compared with people treated with other diabetes medications
& Matlock, D
Others who might be prescribed B12 shots are those at the highest risk for a B12 deficiency, including: Vegans, since vitamin B12 is found only in animal products People ages 60 and up since their bodies don't absorb B12 as efficiently People with Crohn's disease or pancreatic disease, since they prevent nutrient absorption People who had weight-loss surgery, which decreases B12 absorption People with an eating disorder People with HIV People with diabetes Since a mild B12 deficiency might not cause symptoms, it can go undetected for years since levels are not checked during routine blood work
Longevity & Preventive Medicine Many patients in Orange County and Newport Beach seek Epithalon therapy as part of a comprehensive longevity and preventive medicine strategy, aiming to maintain optimal health and potentially extend healthspan through cellular optimization
